Predictors of Long-Term Mortality in Patients With Acute Heart Failure

International Heart Journal
Mengchao JinXinli Li

Abstract

To investigate parameters which were related with long-term mortality in patients hospitalized for acute heart failure (AHF).A total of 287 patients with AHF presenting to the First Affiliated Hospital of Nanjing Medical University were enrolled into the registry from April 2012 to January 2015. The primary endpoint was all-cause mortality within 1 year; the association between variables and prognosis was assessed after 1 year.Among the 287 patients, 17 did not continue follow-up and 47 (17.4%) passed away. Baseline NT-proBNP and sST2 concentrations were higher amongst deceased than among survivors (P < 0.001). Serum sodium concentrations of patients who died were lower (P < 0.001). In receiver operator characteristics (ROC) analyses, the area under the curve (AUC) values for NT-proBNP, sST2, and serum sodium to predict 1-year mortality were 0.699 (95%CI 0.639-0.755), 0.692, (95%CI 0.634-0.747), and 0.694 (95%CI 0.634-0.750), respectively. The optimal cut-off points for NT-proBNP, sST2, and serum sodium were 2137.0 ng/L, 35.711 ng/mL, and 136.6 mmol/L, respectively. In Cox regression analysis, ln-transformed NT-proBNP (HR 1.546, P = 0.039), ln-transformed sST2 (HR1.542, P = 0.049), and serum sodium (HR 0.880, P = 0.000) values ...Continue Reading

References

Jan 14, 2000·Journal of Cardiac Failure·S R Goldsmith
Apr 18, 2000·Heart·J J McMurray, S Stewart
Mar 20, 2001·Archives of Internal Medicine·A H JamaliM B Fowler
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·M ThibonnierM Shoham
Jun 29, 2002·Journal of the American Academy of Nurse Practitioners·Mary Jo Goolsby
Apr 29, 2004·JAMA : the Journal of the American Medical Association·Mihai GheorghiadeUNKNOWN Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure (ACTIV in CHF) Investigators
Mar 15, 2006·Circulation·Wayne C LevyMilton Packer
Jul 25, 2006·QJM : Monthly Journal of the Association of Physicians·J A ClaytonI P Hall
Mar 16, 2007·International Journal of Cardiology·Johannes MairOtmar Pachinger
Mar 27, 2007·JAMA : the Journal of the American Medical Association·Marvin A KonstamUNKNOWN Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators
Mar 27, 2007·JAMA : the Journal of the American Medical Association·Mihai GheorghiadeUNKNOWN Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators
May 1, 2007·Annals of Emergency Medicine·Aaron M BrownJudd E Hollander
May 12, 2007·The Journal of Clinical Investigation·Shoji SanadaRichard T Lee
Sep 12, 2007·Clinical Cardiology·Siva KumarDavid J Whellan
Oct 10, 2007·Archives of Internal Medicine·Mihai GheorghiadeChristopher M O'Connor
Oct 2, 2008·Nature Reviews. Drug Discovery·Rahul Kakkar, Richard T Lee
Sep 2, 2010·Journal of Internal Medicine·T SocratesC Mueller
Jan 14, 2011·Diabetes Care·UNKNOWN American Diabetes Association
May 26, 2011·JAMA : the Journal of the American Medical Association·Urban AlehagenJens P Goetze
Oct 20, 2011·JAMA : the Journal of the American Medical Association·Mihai Gheorghiade, Eugene Braunwald
Mar 30, 2013·European Journal of Heart Failure·Aldo P MaggioniUNKNOWN Heart Failure Association of the European Society of Cardiology (HFA)
Nov 19, 2013·Journal of Cardiac Failure·Tobias BreidthardtChristian Mueller
Jan 9, 2014·International Journal of Cardiology·Christopher CookDarrel P Francis
Jul 27, 2014·Heart Failure Reviews·Pasqualina L SantaguidaParminder Raina
Dec 3, 2014·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·James R Stone
Jan 15, 2015·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Fernando FriõesPaulo Bettencourt
Jul 15, 2015·The Korean Journal of Internal Medicine·Myung Hwan Bae, Shung Chull Chae

❮ Previous
Next ❯

Citations

Mar 23, 2018·International Heart Journal·Fei ChenMao Chen
Dec 7, 2018·International Heart Journal·Sofie VerstrekenMarc Vanderheyden
Apr 24, 2018·International Heart Journal·Zhili XuZhang Wu
Oct 18, 2019·Current Medicinal Chemistry·Vasiliki TsigkouDimitris Tousoulis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Argentine Hemorrhagic Fever

Argentine hemorrhagic fever (AHF) is an endemo-epidemic disease caused by junín virus (JUNV), a member of the arenaviridae family. Discover the latest research on AHF here.

Related Papers

Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
Junjie XiaoSaumya Das
Vojnosanitetski pregled. Military-medical and pharmaceutical review
Marko BanovićMiodrag Ostojić
Critical Care : the Official Journal of the Critical Care Forum
Jindrich SpinarJiri Jarkovsky
© 2022 Meta ULC. All rights reserved